These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9926440)

  • 1. Emerging approaches in the prevention of atherosclerotic cardiovascular diseases.
    Lonn EM; Yusuf S
    Int J Clin Pract Suppl; 1998 May; 94():7-19. PubMed ID: 9926440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
    Antoniades C; Tousoulis D; Tentolouris C; Toutouzas P; Stefanadis C
    Herz; 2003 Nov; 28(7):628-38. PubMed ID: 14689123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on dietary antioxidants and cancer.
    Gaziano JM; Hennekens CH
    Pathol Biol (Paris); 1996 Jan; 44(1):42-5. PubMed ID: 8734299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant vitamins and the prevention of coronary heart disease.
    Adams AK; Wermuth EO; McBride PE
    Am Fam Physician; 1999 Sep; 60(3):895-904. PubMed ID: 10498115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data.
    Marchioli R
    Pharmacol Res; 1999 Sep; 40(3):227-38. PubMed ID: 10479466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant vitamins and zinc for macular degeneration.
    Med Lett Drugs Ther; 2003 Jun; 45(1158):45-6. PubMed ID: 12789135
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
    Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamins and donor hearts.
    SoRelle R
    Circulation; 2002 Apr; 105(14):e9094-5. PubMed ID: 11942341
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antioxidant vitamins - importance for cardiopulmonary prophylaxis. Part II. Antioxidant food supplies - vitamin C and beta-carotene; current experience in antioxidant vitamin usage].
    Andreeva-Gateva P
    Vutr Boles; 2000; 32(4):5-12. PubMed ID: 11688331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of vitamins A, C, and E and their relationship to cardiovascular disease.
    Brown DJ; Goodman J
    Clin Excell Nurse Pract; 1998 Jan; 2(1):10-22. PubMed ID: 12675072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction and antioxidants.
    Duvall WL
    Mt Sinai J Med; 2005 Mar; 72(2):71-80. PubMed ID: 15770336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidant stress as a marker for cardiovascular events: Ox marks the spot.
    Landmesser U; Harrison DG
    Circulation; 2001 Nov; 104(22):2638-40. PubMed ID: 11723010
    [No Abstract]   [Full Text] [Related]  

  • 15. Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor?
    Al-Omran M; Lindsay TF
    Can J Cardiol; 2005 Feb; 21(2):189-93. PubMed ID: 15729421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA; Molnar J; Arora RR
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E does not prevent cardiovascular events in high-risk patients.
    Flynn T; Stevermer JJ
    J Fam Pract; 2000 Apr; 49(4):372-3. PubMed ID: 10778845
    [No Abstract]   [Full Text] [Related]  

  • 18. Antioxidant vitamins do not prevent cardiovascular disease.
    Roychoudhury P; Schwartz K
    J Fam Pract; 2003 Oct; 52(10):751-2. PubMed ID: 14529592
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioxidants: not for prevention.
    Prescrire Int; 2009 Feb; 18(99):34. PubMed ID: 19391300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant vitamins and cardiovascular disease: current knowledge and future directions.
    Hennekens CH
    Nutrition; 1998 Jan; 14(1):50-1. PubMed ID: 9437682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.